Delay of Effective Date: PDMA and Prescription Drug Amendments of 1992
Because the FDA is working with stakeholders through its counterfeit drug initiative to encourage widespread, voluntary adoption of track-and-trace technologies that will generate a de facto electronic pedigree, including prior transaction history back to the original manufacturer,
This premium content is locked for LawJournalNewsletters subscribers only
ENJOY UNLIMITED ACCESS TO THE SINGLE SOURCE OF OBJECTIVE LEGAL ANALYSIS, PRACTICAL INSIGHTS, AND NEWS IN LawJournalNewsletters
- Stay current on the latest information, rulings, regulations, and trends
- Includes practical, must-have information on copyrights, royalties, AI, and more
- Tap into expert guidance from top entertainment lawyers and experts
Already have an account? Sign In Now
For enterprise-wide or corporate access, please contact Customer Service at [email protected] or call 1-877-256-2473.